Helen Heslop, Center for Cell and Gene Therapy director
ASH: Tessa Therapeutics' next-gen cell therapy clears four patients' tumors in early study
Tessa Therapeutics is doing CAR-T a bit differently. After reading out some positive — albeit early — results back in May showing their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
